John M. Griffin
Net Worth

Last updated:

What is John M. Griffin net worth?

The estimated net worth of Mr. John M. Griffin is at least $26,896,230 as of 14 Nov 2022. He owns shares worth $11,423,993 as insider, has earned $3,052,237 from insider trading and has received compensation worth at least $12,420,000 in Hologic, Inc..

What is the salary of John M. Griffin?

Mr. John M. Griffin salary is $1,380,000 per year as Gen. Counsel in Hologic, Inc..

How old is John M. Griffin?

Mr. John M. Griffin is 64 years old, born in 1961.

What stocks does John M. Griffin currently own?

As insider, Mr. John M. Griffin owns shares in one company:

Company Title Shares Price per share Total value
Hologic, Inc. (HOLX) Gen. Counsel 168,944 $67.62 $11,423,993

What does Hologic, Inc. do?

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

HOLX logo
HOLX
Hologic, Inc.
$67.62

John M. Griffin insider trading

Hologic, Inc.

Mr. John M. Griffin has made 7 insider trades between 2016-2022, according to the Form 4 filled with the SEC. Most recently he sold 23,634 units of HOLX stock worth $1,797,909 on 14 Nov 2022.

The largest trade he's ever made was exercising 38,014 units of HOLX stock on 7 Nov 2017. As of 14 Nov 2022 he still owns at least 168,944 units of HOLX stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 23,634 $76.07 $1,797,909
Sale
Common Stock 3,268 $76.49 $249,979
Option
Common Stock 26,902 $40.85 $1,098,947
Option
Non-qualified Stock Option (Right to Buy) 26,902 $40.85 $1,098,947
Option
Common Stock 26,683 $37.64 $1,004,348
Option
Non-qualified Stock Option (Right to Buy) 26,683 $37.64 $1,004,348
Sale
Common Stock 26,683 $37.64 $1,004,348
Sale
Common Stock 22,900 N/A N/A
Option
Common Stock 22,900 N/A N/A
Option
Non-qualified Stock Option (Right to Buy) 22,900 N/A N/A
Sale
Common Stock 22,900 N/A N/A
Option
Non-qualified Stock Option (Right to Buy) 2,773 N/A N/A
Option
Common Stock 4,906 N/A N/A
Sale
Common Stock 2,773 N/A N/A
Sale
Common Stock 8,532 N/A N/A
Option
Non-qualified Stock Option (Right to Buy) 19,624 N/A N/A
Option
Common Stock 19,624 N/A N/A
Option
Common Stock 2,376 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 1,343 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 2,503 N/A N/A
Option
Common Stock 2,503 N/A N/A
Option
Common Stock 2,376 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 2,376 N/A N/A
Option
Performance Stock Unit Award (Right to Receive) 21,486 N/A N/A
Option
Common Stock 38,014 N/A N/A
Option
Common Stock 2,502 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 2,502 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 2,376 N/A N/A
Option
Common Stock 2,376 N/A N/A
Option
Common Stock 2,502 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 2,502 N/A N/A
Option
Restricted Stock Unit Award (Right To Receive) 2,375 N/A N/A
Option
Common Stock 2,375 N/A N/A

Hologic key executives

Hologic, Inc. executives and other stock owners filed with the SEC: